RxDoctor Payments Data

Teresa Stanford, NP

Nurse Practitioner · Amory, MSNPI 1245246099

Payments from drug & device makers

$2,390in general payments, 2019–2025

Across 124 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$733
  • Amgen$492
  • Abbott$283
  • Daiichi Sankyo Inc.$135
  • AstraZeneca$120
  • Boehringer Ingelheim$120
  • plus $508 from 12 others

What the payments were for

  • Food & beverage$2,390100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,390 in reported general payments places this provider in the 85th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$194,659
Medicare patients
424
Services billed
5,104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide84$106,606
JardianceEmpagliflozin60$79,080
EliquisApixaban65$57,906
OzempicSemaglutide33$39,688
MounjaroTirzepatide22$22,322
JanuviaSitagliptin Phosphate16$11,222
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,944
Gabapentin266$5,696
SymbicortBudesonide/Formoterol Fumarate14$3,929
Metoprolol Succinate230$3,092
Albuterol Sulfate HfaAlbuterol Sulfate117$2,783
Rosuvastatin Calcium285$2,715
Atorvastatin Calcium383$2,591
Omeprazole204$2,405
Levothyroxine Sodium269$2,216

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$733$128,928106 claims
Boehringer IngelheimJardiance$120$79,08060 claims
PfizerEliquis$41$57,90665 claims
Novo NordiskOzempic$61$39,68833 claims
AstraZenecaBreztri Aerosphere, Symbicort$120$12,87328 claims
AbbVieSynthroid$91$1,89526 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Amory

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →